Skip to main content

Table 1 Demographic characteristics of the seven study patients

From: Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation

Patient

Age (years)

Weight (kg)

Height (cm)

SAPS II score

Urine output (ml/24 hours)a

Residual glomerular filtration rate (ml/min)b

1

65

76

170

42

300

<1

2

43

70

195

46

50

<1

3

51

76

165

28

1,650

5

4

71

89

178

64

0

0

5

46

61

183

65

150

<1

6

68

83

168

63

300

<1

7

68

88

163

64

100

<1

  1. aMean daily urine output during time of pharmacokinetic sampling. bCreatinine clearance measured at the inclusion; if necessary, continuous venovenous haemodiafiltration was stopped before enrollment to assess creatinine clearance. SAPS, Simplified Acute Physiologic Score.